Principal Financial Group Inc. Has $9.39 Million Holdings in LeMaitre Vascular, Inc. (NASDAQ:LMAT)

Principal Financial Group Inc. raised its stake in LeMaitre Vascular, Inc. (NASDAQ:LMAT - Free Report) by 3.0% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 111,865 shares of the medical instruments supplier's stock after acquiring an additional 3,248 shares during the quarter. Principal Financial Group Inc. owned about 0.50% of LeMaitre Vascular worth $9,385,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors also recently modified their holdings of the business. Consolidated Planning Corp acquired a new stake in shares of LeMaitre Vascular during the 1st quarter worth approximately $947,000. Johnson Investment Counsel Inc. grew its position in shares of LeMaitre Vascular by 34.8% during the 1st quarter. Johnson Investment Counsel Inc. now owns 29,428 shares of the medical instruments supplier's stock worth $2,469,000 after buying an additional 7,603 shares during the period. Opal Wealth Advisors LLC acquired a new stake in shares of LeMaitre Vascular during the 1st quarter worth approximately $26,000. Fifth Third Bancorp grew its position in shares of LeMaitre Vascular by 2.3% during the 1st quarter. Fifth Third Bancorp now owns 10,903 shares of the medical instruments supplier's stock worth $915,000 after buying an additional 246 shares during the period. Finally, Dividend Assets Capital LLC acquired a new stake in shares of LeMaitre Vascular during the 1st quarter worth approximately $3,877,000. Institutional investors and hedge funds own 84.64% of the company's stock.

Insider Transactions at LeMaitre Vascular

In other news, CEO George W. Lemaitre sold 76,868 shares of the company's stock in a transaction that occurred on Monday, May 19th. The shares were sold at an average price of $85.79, for a total value of $6,594,505.72. Following the completion of the transaction, the chief executive officer owned 1,796,783 shares in the company, valued at $154,146,013.57. This represents a 4.10% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Insiders have sold a total of 100,000 shares of company stock worth $8,556,857 in the last ninety days. 9.50% of the stock is currently owned by insiders.

LeMaitre Vascular Trading Up 0.5%

NASDAQ LMAT traded up $0.38 during trading on Wednesday, reaching $82.61. 103,948 shares of the stock traded hands, compared to its average volume of 169,087. The firm has a market cap of $1.87 billion, a price-to-earnings ratio of 41.72, a price-to-earnings-growth ratio of 2.17 and a beta of 0.82. The stock's 50-day moving average price is $82.81 and its 200 day moving average price is $87.93. The company has a quick ratio of 13.83, a current ratio of 16.49 and a debt-to-equity ratio of 0.48. LeMaitre Vascular, Inc. has a fifty-two week low of $71.42 and a fifty-two week high of $109.58.

LeMaitre Vascular (NASDAQ:LMAT - Get Free Report) last issued its quarterly earnings data on Thursday, May 1st. The medical instruments supplier reported $0.48 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.50 by ($0.02). The firm had revenue of $59.87 million for the quarter, compared to analyst estimates of $57.61 million. LeMaitre Vascular had a net margin of 19.96% and a return on equity of 13.53%. The firm's revenue for the quarter was up 12.0% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.44 EPS. Analysts predict that LeMaitre Vascular, Inc. will post 1.94 EPS for the current year.

LeMaitre Vascular Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Thursday, May 29th. Investors of record on Thursday, May 15th were issued a dividend of $0.20 per share. This represents a $0.80 dividend on an annualized basis and a yield of 0.97%. The ex-dividend date of this dividend was Thursday, May 15th. LeMaitre Vascular's dividend payout ratio is currently 40.40%.

LeMaitre Vascular Company Profile

LeMaitre Vascular, Inc develops, manufactures, and markets medical devices and implants used in the field of vascular surgery worldwide. It offers human cadaver tissue cryopreservation services; angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries; thrombectomy catheters for removing thrombi in the venous system; occlusion catheters that temporarily occlude the blood flow; and perfusion catheters to perfuse the blood and other fluids into the vasculature.